Notably, HK2 is overexpressed in many aggressive tumors and localized to mitochondrial outer membrane attaining higher conformational stability compared to cytosolic HK2 (Pedersen et al., 2002; Anderson et al., 2017) suggesting, HK2 as a novel target for drug discovery against a multitude of cancers. The gene discussed is HK2; the disease is cancer.